C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.69 CAD 1.2% Market Closed
Market Cap: 160.4m CAD

Intrinsic Value

The intrinsic value of one LOVE stock under the Base Case scenario is 2.74 CAD. Compared to the current market price of 1.69 CAD, Cannara Biotech Inc is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LOVE Intrinsic Value
2.74 CAD
Undervaluation 38%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cannara Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about LOVE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LOVE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cannara Biotech Inc.

Explain Valuation
Compare LOVE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LOVE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cannara Biotech Inc

Current Assets 82.2m
Cash & Short-Term Investments 14.4m
Receivables 14.1m
Other Current Assets 53.7m
Non-Current Assets 86.5m
PP&E 86m
Other Non-Current Assets 487.8k
Current Liabilities 34.2m
Accounts Payable 11m
Accrued Liabilities 9.8m
Short-Term Debt 6.8m
Other Current Liabilities 6.7m
Non-Current Liabilities 32.2m
Long-Term Debt 28.3m
Other Non-Current Liabilities 3.9m
Efficiency

Free Cash Flow Analysis
Cannara Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cannara Biotech Inc

Revenue
107.3m CAD
Cost of Revenue
-89.7m CAD
Gross Profit
17.6m CAD
Operating Expenses
-25.4m CAD
Operating Income
-7.8m CAD
Other Expenses
20.9m CAD
Net Income
13.1m CAD
Fundamental Scores

LOVE Profitability Score
Profitability Due Diligence

Cannara Biotech Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

42/100
Profitability
Score

Cannara Biotech Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

LOVE Solvency Score
Solvency Due Diligence

Cannara Biotech Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
48/100
Solvency
Score

Cannara Biotech Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LOVE Price Targets Summary
Cannara Biotech Inc

Wall Street analysts forecast LOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LOVE is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

Lowest
Price Target
3.54 CAD
109% Upside
Average
Price Target
3.57 CAD
111% Upside
Highest
Price Target
3.68 CAD
117% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cannara Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LOVE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one LOVE stock?

The intrinsic value of one LOVE stock under the Base Case scenario is 2.74 CAD.

Is LOVE stock undervalued or overvalued?

Compared to the current market price of 1.69 CAD, Cannara Biotech Inc is Undervalued by 38%.

Back to Top